Ameripath Group Holdings, Inc.

Ameripath Group Holdings, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Quest Diagnostics Incorporated, which provides emissions data cascaded from its parent organisation. However, no specific emissions figures or reduction targets have been reported for Ameripath Group Holdings, Inc.

As part of its corporate family relationship, Ameripath may align with the climate commitments and initiatives of Quest Diagnostics. This includes potential participation in industry-standard frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), although specific targets or commitments have not been disclosed for Ameripath itself.

In summary, while Ameripath Group Holdings, Inc. does not currently report its own emissions or reduction targets, it is positioned within a corporate structure that may influence its climate strategies through its relationship with Quest Diagnostics.